The effects of droperidol on modifying the hypertensive response to ketamine.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002648:Child; D004285:Dogs; D004329:Droperidol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007649:Ketamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D008297:Male; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D007649:Ketamine; D012601:Scopolamine; D004329:Droperidol